DrugCendR Inc. — Form D
DrugCendR Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-29. The offering totals $1.5M, of which $1.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-05-29
- Form: D
- Accession: 0001729308-18-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.1M
- Remaining: $400K
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2018-04-03
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-313359
Issuer
- Name: DrugCendR Inc.
- CIK: 0001729308
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2016
- Address: 10901 N TORREY PINES RD, LA JOLLA, CA, 92037
- Phone: 8586463101
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Erkki Ruoslahti | Executive Officer | La Jolla, CA |
Other filings by this issuer (1)
More